Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV1.7 sodium channels
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV1.7 sodium channels
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 19, Pages 4455-4463
Publisher
Wiley
Online
2014-05-28
DOI
10.1111/bph.12788
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- A Novel SCN9A Mutation Responsible for Primary Erythromelalgia and Is Resistant to the Treatment of Sodium Channel Blockers
- (2013) Min-Tzu Wu et al. PLoS One
- Painful Na-channelopathies: an expanding universe
- (2013) Stephen G. Waxman TRENDS IN MOLECULAR MEDICINE
- Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia
- (2012) Jeffrey M. Statland JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Modulation of neuronal sodium channels by the sea anemone peptide BDS-I
- (2012) Pin Liu et al. JOURNAL OF NEUROPHYSIOLOGY
- Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians
- (2012) Juan Zhao et al. JOURNAL OF PHYSIOLOGY-LONDON
- Imaging the neural correlates of neuropathic pain and pleasurable relief associated with inherited erythromelalgia in a single subject with quantitative arterial spin labelling
- (2012) Andrew R. Segerdahl et al. PAIN
- Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Nav1.7 mutant channel
- (2012) Yang Yang et al. Nature Communications
- Deletion mutation of sodium channel NaV1.7 in inherited erythromelalgia: enhanced slow inactivation modulates dorsal root ganglion neuron hyperexcitability
- (2011) X. Cheng et al. BRAIN
- Lidocaine reduces the transition to slow inactivation in Nav1.7 voltage-gated sodium channels
- (2011) Patrick L Sheets et al. BRITISH JOURNAL OF PHARMACOLOGY
- Intra- and Interfamily Phenotypic Diversity in Pain Syndromes Associated with a Gain-of-Function Variant of NaV1.7
- (2011) Mark Estación et al. Molecular Pain
- Intravenous Lidocaine and Mexiletine in the Management of Trigeminal Autonomic Cephalalgias
- (2010) Michael J. Marmura Current Pain and Headache Reports
- A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia
- (2009) Tanya Z. Fischer et al. ANNALS OF NEUROLOGY
- The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment
- (2009) E. Matthews et al. BRAIN
- Mexiletine-responsive erythromelalgia due to a new Nav1.7 mutation showing use-dependent current fall-off
- (2009) Jin-Sung Choi et al. EXPERIMENTAL NEUROLOGY
- Compound Heterozygosity in Sodium Channel Nav1.7 in a Family with Hereditary Erythermalgia
- (2008) Mark E Samuels et al. Molecular Pain
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now